Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 24, 2014

Primary Completion Date

December 8, 2017

Study Completion Date

December 8, 2017

Conditions

Peptic Ulcer

Interventions

DRUG

Placebo

Drug : Placebo

DRUG

PMK-S005 1

Drug : PMK-S005 1 (50mg)

DRUG

PMK-S005 2

Drug : PMK-S005 2 (100mg)

DRUG

PMK-S005 3

Drug : PMK-S005 3 (150mg)

Trial Locations (1)

Bundang Seoul University Hospital, Kumi-dong